HomeCompareHLUYY vs KMB

HLUYY vs KMB: Dividend Comparison 2026

HLUYY yields 21.52% · KMB yields 5.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HLUYY wins by $34.2K in total portfolio value
10 years
HLUYY
HLUYY
● Live price
21.52%
Share price
$22.00
Annual div
$4.73
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$80.1K
Annual income
$7,902.94
Full HLUYY calculator →
KMB
KMB
● Live price
5.25%
Share price
$96.35
Annual div
$5.06
5Y div CAGR
17%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$45.9K
Annual income
$5,222.34
Full KMB calculator →

Portfolio growth — HLUYY vs KMB

📍 HLUYY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHLUYYKMB
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HLUYY + KMB cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HLUYY pays
KMB pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HLUYY
Annual income on $10K today (after 15% tax)
$1,829.43/yr
After 10yr DRIP, annual income (after tax)
$6,717.50/yr
KMB
Annual income on $10K today (after 15% tax)
$446.39/yr
After 10yr DRIP, annual income (after tax)
$4,438.99/yr
At 15% tax rate, HLUYY beats the other by $2,278.51/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HLUYY + KMB for your $10,000?

HLUYY: 50%KMB: 50%
100% KMB50/50100% HLUYY
Portfolio after 10yr
$63.0K
Annual income
$6,562.64/yr
Blended yield
10.41%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on KMB right now

HLUYY
Analyst Ratings
1
Hold
Consensus: Hold
KMB
Analyst Ratings
9
Buy
19
Hold
3
Sell
Consensus: Hold
Price Target
$123.00
+27.7% upside vs current
Range: $102.00 — $162.00
Altman Z
3.4
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HLUYY buys
0
KMB buys
0
No recent congressional trades found for HLUYY or KMB in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHLUYYKMB
Forward yield21.52%5.25%
Annual dividend / share$4.73$5.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%17%
Portfolio after 10y$80.1K$45.9K
Annual income after 10y$7,902.94$5,222.34
Total dividends collected$47.3K$21.6K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusHoldHold

Year-by-year: HLUYY vs KMB ($10,000, DRIP)

YearHLUYY PortfolioHLUYY Income/yrKMB PortfolioKMB Income/yrGap
1← crossover$12,852$2,152.27$11,314$614.45+$1.5KHLUYY
2$16,337$2,585.20$12,867$760.19+$3.5KHLUYY
3$20,552$3,071.18$14,713$945.27+$5.8KHLUYY
4$25,601$3,610.76$16,924$1,181.90+$8.7KHLUYY
5$31,597$4,203.63$19,596$1,486.64+$12.0KHLUYY
6$38,657$4,848.69$22,850$1,882.16+$15.8KHLUYY
7$46,908$5,544.07$26,849$2,399.80+$20.1KHLUYY
8$56,478$6,287.15$31,812$3,083.36+$24.7KHLUYY
9$67,506$7,074.71$38,033$3,994.72+$29.5KHLUYY
10$80,135$7,902.94$45,918$5,222.34+$34.2KHLUYY

HLUYY vs KMB: Complete Analysis 2026

HLUYYStock

H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia. It also provides Azilect for treating Parkinson's disease; Cipralex/Lexapro for depression; Ebixa to treat Alzheimer's disease; Onfi for Lennox-Gastaut syndrome; Sabril for treating epilepsy; and Xenazine for chorea associated with Huntington's disease, as well as other products. The company sells its products primarily to distributors of pharmaceuticals, pharmacies, and hospitals. It has a partnership agreement with Verantos to focus on a study to enable real-world evidence in support of migraine therapy; and collaboration with Rgenta Therapeutics, Inc. The company was founded in 1915 and is headquartered in Valby, Denmark.

Full HLUYY Calculator →

KMBConsumer Staples

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, swimpants, training and youth pants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and other brand names. The Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The K-C Professional segment offers wipers, tissues, towels, apparel, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. The company sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to manufacturing, lodging, office building, food service, and public facilities, as well as through distributors and e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.

Full KMB Calculator →
📬

Get this HLUYY vs KMB comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HLUYY vs SCHDHLUYY vs JEPIHLUYY vs OHLUYY vs KOHLUYY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.